SCHEMBL11047281

SCHEMBL11047281

CCCCCCCCCC(=O)NC(C(=O)O)C(C)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
MAPK1 P28482 1/20 0.62
NOD1 Q9Y239 3/20 0.55
PLA2G2A P14555 1/20 0.55
PLA2G5 P39877 1/20 0.55
ALDH1A1 P00352 1/20 0.52
ASAH1 Q13510 1/20 0.52
ACER2 Q5QJU3 1/20 0.52
DNM1 Q05193 1/20 0.51
PLA2G2C Q5R387 1/20 0.51
PLA2G10 O15496 2/20 0.51
ASAH2 Q9NR71 1/20 0.50
HSP90AA1 P07900 1/20 0.48
SLC6A5 Q9Y345 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5667184 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL17204243 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL543568 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL17203963 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL8823482 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL7268170 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL25196976 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL11047279 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL7269318 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1
SCHEMBL338364 1.00 FAAH (0.62) FAAHMEN1KMT2AMAPK1NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250073673-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC. (CA) 2025-03-06 US claimed
EP-4414063-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE Carbonet Nanotechnologies Inc. (CA) 2024-08-14 EP claimed
EP-4414063-B1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC (CA) 2026-04-15 EP disclosed
US-20250073673-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC. (CA) 2025-03-06 US disclosed
US-12226750-B2 Nanonets for removal of contaminants from aqueous solutions, kits therefor and methods of their use CARBONET NANOTECHNOLOGIES INC. (CA) 2025-02-18 US disclosed
EP-4414063-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE Carbonet Nanotechnologies Inc. (CA) 2024-08-14 EP disclosed
EP-3377473-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2024-06-19 EP disclosed
EP-3891102-B1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC (CA) 2024-04-17 EP disclosed
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
US-20230035776-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC. (CA) 2023-02-02 US disclosed
CN-108884058-B Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2022-04-29 CN disclosed
WO-2019071213-A1 RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS RECEPTOR LIFE SCIENCES, INC. (US) 2019-04-11 WO disclosed
WO-2019071211-A1 HERBAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY RECEPTOR LIFE SCIENCES, INC. (US) 2019-04-11 WO disclosed
WO-2018102029-A1 FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS RECEPTOR LIFE SCIENCES (US) 2018-06-07 WO disclosed
WO-2017185038-A1 FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS RECEPTOR LIFE SCIENCES (US) 2017-10-26 WO disclosed
US-9309486-B2 Cleaning agent composition AJINOMOTO CO., INC. (JP) 2016-04-12 US disclosed
EP-2703478-B1 CLEANING AGENT COMPOSITION AJINOMOTO KK (JP) 2016-03-23 EP disclosed
EP-2703478-A1 CLEANING AGENT COMPOSITION Ajinomoto Co., Inc. (JP) 2014-03-05 EP disclosed
US-20140051772-A1 CLEANING AGENT COMPOSITION AJINOMOTO CO., INC. (JP) 2014-02-20 US disclosed
US-4442090-A ACYLATED AMINO ACID KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) 1984-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051772-A1 CLEANING AGENT COMPOSITION SORT1, ASAH1, ABHD16A FAAH 13/4885MEN1 4813/4885KMT2A 1349/4885
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC FAAH 3193/4885MEN1 2531/4885KMT2A 3283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.